RP11-284N8.3.1

Gene basic information

SymbolRP11-284N8.3.1
Tissueovary,
Cancerovarian cancer,


Description

LncRNA RP11-284N8.3.1 is down-regulated in ovarian cancer. It could significantly divide late-stage patients into high- and low-risk groups. Moreover, RP11-284N8.3.1 expression level is associated with a decreased risk of survival. Low-risk groups always have higher expression level of RP11-284N8.3.1 than the high-risk groups. In addition, RP11-284N8.3.1 is significantly associated with patient progression-free survival. Besides, RP11-284N8.3.1 involves in immune- and cell-cycle-associated processes (1).


Cancer related information

download as excel csv txt

LncRNA tissue cancer type expression level oncogene/suppress gene pathway binding gene/factor associated gene/factor proliferation apoptosis migration EMT invasion metastasis prognosis tag PMID
0 RP11-284N8.3.1 ovary ovarian cancer / TS immune-associated genes + 26631459

Expression profile

adipose adrenal brain breast colon heart kidney leukocyte liver lung lymph node ovary prostate skeletal muscle testis thyroid tissue 0 5 10 15 20 25 fpkm 0.1 6.0 3.0 0.5 0.5 0.1 0.2 28.0 0.3 5.0 28.0 1.0 0.4 0.0 0.4 0.1 RP11-284N8.3.1

Expression profile in human body map

TCGA-BLCA TCGA-BRCA TCGA-CESC TCGA-HNSC TCGA-KICH TCGA-KIRC TCGA-KIRP TCGA-LIHC TCGA-LUAD TCGA-LUSC TCGA-PRAD TCGA-STAD TCGA-THCA TCGA-UCEC tissue 0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 fpkm RP11-284N8.3.1 type normal tumor

Expression profile in TCGA


Genomic feature visualization


Sequence

Literature

[1]. Guo Q, Cheng Y, Liang T, He Y, Ren C, et al. (2015). Comprehensive analysis of lncRNA-mRNA co-expression patterns identifies immune-associated lncRNA biomarkers in ovarian cancer malignant progression. Sci Rep 5: 17683. link pubmed



© Bioinformatics Group of XTBG